Evidence map›Paper›PMID 41450424›Full record

ArticleCureus2025

The Burden of Atherosclerotic Cardiovascular Disease Risk Factors Among Adults Living With HIV in the Ashanti Region: A Cross-Sectional Study in Kumasi.

Manasseh B Wireko, Patrick W Narkwa, Emmanuel A Ntim, Lorraine Sallah, Betty Norman, Jacobus Hendricks, Kweku Bedu-Addo, Marlise V Staden, John A Larbi, Isaac K Owusu

Abstract read
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Manasseh B WirekoBiological Science Education, Akenten Appiah-Menka University of Skills Training and Entrepreneurial Development, Kumasi, GHA.
Patrick W NarkwaClinical Microbiology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Emmanuel A NtimPhysiology, School of Medical Sciences, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Lorraine SallahPhysiology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Betty NormanInternal Medicine, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Jacobus HendricksPhysiology and Environmental Health, University of Limpopo, Limpopo, ZAF.
Kweku Bedu-AddoPhysiology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Marlise V StadenPhysiology and Environmental Health, University of Limpopo, Limpopo, ZAF.
John A LarbiTheoretical and Applied Biology, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.
Isaac K OwusuMedicine, Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, GHA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The burden of atherosclerotic cardiovascular disease (ASCVD) in sub-Saharan Africa (SSA) is increasing rapidly. Risk factor assessment is necessary for specific and strategic interventions to curb the high ASCVD burden. Evidence suggests that people living with HIV (PLWH) are at greater risk of ASCVD compared to HIV-negative individuals, as they spend many years on highly active antiretroviral therapy (HAART). This study therefore sought to explore the prevalence of ASCVD risk factors among adults receiving HAART in the Ashanti Region. Methods A hospital-based cross-sectional study design and systematic sampling were used to recruit 254 PLWH. Anthropometric measurements and lifestyle factors, including alcohol consumption, were assessed using the WHO STEPS protocol. Blood pressure measurements and blood samples were taken to determine participants' blood sugar levels (HbA1c) and lipid profiles. Participants' HAART history was obtained from their medical record cards. Chi-square tests were used to assess differences in categorical ASCVD risk outcomes, while one-way ANOVA was used to determine differences in mean values of continuous risk factors. Results Most participants were female (85.43% (n=217)). The mean age was 51.78 years (±10.24); male participants were slightly older (54.67 years (±11.52)) than females (51.29 years (±9.96)), although this difference was not statistically significant (P=0.0674). The majority were self-employed (85.11% (n=183)), and most were non-consumers of alcohol (88.97% (n=226)). Only 11.02% (n=28) consumed alcohol, and among them, 40.74% (n=11) were occasional consumers, with females comprising most of the occasional drinkers (90% (n=10)). Females had significantly higher BMI than males (women: 26.59 (±7.27), men: 23.29 (±5.12), P=0.008). However, males had higher abdominal obesity than females (women: 0.89 (±0.08), men: 0.97 (±0.07), P=0.0006). About 22.4% of participants had metabolic syndrome (Std. Err. 0.026, 95% CI: 0.281-0.3199). Middle-aged individuals had 3.55 times higher odds of hypertension compared to younger adults (OR = 3.55 (95% CI: 1.51-8.37), P=0.004), and older adults had 6.85 times higher odds compared to younger adults (OR = 6.85 (95% CI: 2.21-21.28), P=0.001). The study showed a crude prevalence of diabetes mellitus of 25.21% (n=30/119, 95% CI: 17.5%-34.4%), and the adjusted diabetes prevalence increased to 30.3% (95% CI: 24.7%-36.0%). Conclusion ASCVD risk factors were relatively high among PLWH. Screening for ASCVD should begin in middle-aged PLWH for early detection, and primary CVD preventive measures should be implemented to reduce the ASCVD burden.

Indexed as

atherosclerotic cardiovascular disease (ascvd)diabetes mellitusdyslipidemiahighly active antiretroviral therapy (haart)hypertensionmetabolic syndromeobesitysub-saharan africa

Identifiers

PMID41450424
PMCPMC12728887

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.